SCHEMBL29327905

SCHEMBL29327905

C=C(F)c1cccc(F)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 0.58
▸ CES1 P23141 2/20 0.58
▸ PARP1 P09874 1/20 0.54
▸ HDAC1 Q13547 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ PLA2G7 Q13093 1/20 0.44
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CTSL P07711 1/20 0.42
▸ KCNK3 O14649 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ ACHE P22303 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ HPGD P15428 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20494918 0.85 TDP1 (0.40) CES2CES1PARP1HDAC1HDAC6
SCHEMBL28863383 0.83 CES2 (0.60) CES2CES1PARP1HDAC1HDAC6
SCHEMBL16953336 0.80 CES2 (0.62) CES2CES1PARP1HDAC1HDAC6
SCHEMBL6862739 0.79 CES2 (0.56) CES2CES1PARP1HDAC1HDAC6
SCHEMBL27864984 0.79 CES2 (0.56) CES2CES1PARP1HDAC1HDAC6
SCHEMBL29174153 0.77 CES2 (0.54) CES2CES1PARP1HDAC1HDAC6
SCHEMBL4078123 0.77 CES2 (0.65) CES2CES1PARP1HDAC1HDAC6
SCHEMBL10703733 0.76 CES2 (0.71) CES2CES1PARP1HDAC1HDAC6
SCHEMBL12831681 0.76 CES2 (0.52) CES2CES1PARP1HDAC1HDAC6
SCHEMBL16661501 0.76 ENPP2 (0.48) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400500-A1 HALOGEN-SUBSTITUTED PYRIDAZINONE COMPOUND AND APPLICATION THEREOF Medshine Discovery Inc. (CN) 2024-07-17 — — EP disclosed
Send feedback